Results 151 to 160 of about 33,667 (245)

RAD51 and RAD51 paralog inhibition sensitizes nonreplicating quiescent keratinocytes to UV radiation

Photochemistry and Photobiology, Volume 102, Issue 5, Page 1138-1149, September/October 2026.
UV radiation and other compounds generate DNA adducts that block transcription and induce cell death if not removed by the nucleotide excision repair system. In this work, we used a small‐scale pharmacological screen to discover that inhibition of the recombinase RAD51 sensitized nonreplicating quiescent keratinocytes to both UVR and other agents that ...
Saman Khan, Angitha Nair, M. Alexandra Carpenter, Michael G. Kemp   +3 more
wiley   +1 more source

Spotlight July–September 2026: What's New in JEADV—Editor‐in‐Chief's Selection

JEADV Clinical Practice, Volume 5, Issue 3, Page 763-768, September 2026.
Carle Paul
wiley   +1 more source

Patterns of spironolactone management following hyperkalemia among hospitalized patients with heart failure and reduced ejection fraction: a retrospective single-center study. [PDF]

Front Med (Lausanne)
Alshammari AS, Bahamdain FO, Alshahrani AM, Kandasamy G, Rabea Mussa Rabea A, Alyamani W, Idris A, Kamfar Y, Almalki M, Alghamdi S, Kanan M, Bifari N, Alsulami S, Alotaibi AS, Elkholy E.   +14 more
europepmc   +1 more source

Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety. [PDF]

Dermatol Ther (Heidelb)
Gil-Redondo R, Jimenez-Cauhe J, Imbernon-Moya A, Buendía-Castaño D, Burgos Blasco P, Díaz-Guimaraens B, Domínguez-Santas M, Hermosa-Gelbard Á, Saceda-Corralo D, Vañó-Galván S.   +9 more
europepmc   +1 more source

PRO/CON debate: nonsteroidal versus steroidal mineralocorticoid receptor antagonists in chronic kidney disease: progress, pragmatism, and remaining uncertainties. [PDF]

Clin Kidney J
Agarwal R, Vogt L, Floege J, Zoccali C.
europepmc   +1 more source

Spironolactone therapy in older patients - The impact of renal dysfunction

, 2002
Low dose spironolactone reduces the risk of death from heart failure. We examined the effects of spironolactone on potassium homeostasis in a cohort of elderly patients with congestive heart failure (CHF). Eighteen patients >70 years, mean 80.5 (+/- SD 6.
Mulkerrin, E., McAvoy, H.
core  

Sex-Specific Safety Signals of Finerenone Versus Spironolactone: Insights From the FDA Adverse Event Reporting System. [PDF]

Cureus
Singla A, Singh G, Kaur G, Luthra S, Lodha C, Malik MS, Kalsoom S, Alo MS, Ali SS, Zulqarnain M.   +9 more
europepmc   +1 more source

Upregulated Renal Mineralocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase Type 2 Are Associated with K⁺ Retention During MR Antagonism in Female Spontaneously Hypertensive Rats. [PDF]

Int J Mol Sci
Baranovskaya I, Bilous I, Alexander S, Tubalinal B, Cherezova A, Buncha V, Fomin M, Gomez-Sanchez C, Mamenko M.   +8 more
europepmc   +1 more source

Risk of Hyperkalemia in Patients with Heart Failure Treated with Spironolactone in Combination with Sacubitril/Valsartan vs. Renin-Angiotensin System Inhibitors. [PDF]

Clin Pharmacol Ther
Crum KL, Vaduganathan M, Desai RJ.
europepmc   +1 more source

Finerenone Alleviates Cardiac Microvascular Injury and Neutrophil Extracellular Traps Formation in Diabetic Cardiomyopathy via Regulating AKT1 Phosphorylation. [PDF]

Acta Physiol (Oxf)
Li S, Zhang H, Liu M, Zhu W, Yan X, Qiu W, Tian Y, Lian X, Lu D, Chen Z, Chen C, Chen Y, Qian J.   +12 more
europepmc   +1 more source